KBE vs XBI
SPDR S&P Bank ETF vs SPDR S&P Biotech ETF
- • KBE pays a higher dividend yield (2.15%).
Side-by-side metrics
| Metric | KBE | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.15% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $1.48B | $10.73B |
YTD return | 11.95% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.12 | 1.10 |
P/E ratio | 13.74 | — |
Last price | $68.32 | $164.28 |
Inception | — | — |
Issuer | State Street | State Street |
KBE top holdings
| RKT | Rocket Companies Inc Ordinary Shares Class A | 1.17% |
| NIC | Nicolet Bankshares Inc | 1.07% |
| TBBK | The Bancorp Inc | 1.06% |
| NMIH | NMI Holdings Inc | 1.04% |
| AX | Axos Financial Inc | 1.03% |
| MTG | MGIC Investment Corp | 1.02% |
| ESNT | Essent Group Ltd | 1.02% |
| AUB | Atlantic Union Bankshares Corp | 1.02% |
| WSBC | Wesbanco Inc | 1.02% |
| PFSI | PennyMac Financial Services Inc Class A | 1.02% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About KBE
KBE (SPDR S&P Bank ETF) is US banking industry stocks, broad coverage. Managed by State Street, the fund carries $1.5B in assets under management, an expense ratio of 0.35%, a dividend yield of 2.15%. Its largest holding is Rocket Companies Inc Ordinary Shares Class A (RKT), which represents 1.2% of the portfolio. Financial Services is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.